drugset / Trial / NCT00765726
Study Evaluating The Safety Of Xyntha In Usual Care Settings
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to collect safety information associated with the use of Xyntha in a usual care setting. Upon meeting eligibility criteria, patients will be required to have approximately 5 study visits over a 2 year period. Procedures completed throughout the study include collection of vital signs, physical exams, and laboratory assessments. Patients will be required to complete an infusion log for each Xyntha infusion.
Timeline
- Start
- 2009-02
- Primary completion
- 2011-07
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moroctocog alfa | Protein / enzyme biologic | — | — |